FDA panel supports Moderna booster shot for older adults, people at high risk
Oct 14, 2021
Panelists recommended that everyone aged 65 years or older who received the two-dose Moderna regimen get a third dose.
Demand for monkeypox vaccine overwhelms U.S. cities
Jul 14, 2022
Infections from monkeypox have now passed 1,000 cases in the United States.
Rare cases of COVID-19 relapse seen with Pfizer pill
May 10, 2022
There are reports of symptoms returning in patients several days after completing the five-day regimen of Paxlovid.
Vaccine effectiveness high for preventing COVID-19 hospitalization
Sep 15, 2021
Vaccine effectiveness was 86% against COVID-19 hospitalization overall and was significantly lower among adults aged 75 years and older versus those aged 18 to 74 years (76% versus 89%).
Omicron might help shield against delta, new research suggests
Dec 29, 2021
As omicron appears to produce less severe illness than delta, its overall effect might end up having a positive side.
FDA questions strength of Johnson & Johnson booster shot data
Oct 13, 2021
The agency says a key test used by the company to measure immune response from booster shot six months after the original shot was likely not sensitive enough.
Nearly 200,000 COVID-19 home tests recalled over false positives
Oct 06, 2021
The problem with the Ellume rapid antigen tests was caused by variations in the quality of one of the raw materials used in the products.
Fauci has ‘rebound’ COVID after Paxlovid treatment
Jun 30, 2022
The director of the NIAID says the drug kept him out of the hospital, however.
ACR: COVID-19 vaccine not tied to severe rheumatic disease flares
Nov 10, 2021
Seropositivity lags after vaccination in those with rheumatic diseases but improves after second dose.
Sleep disturbance common, tied to pain, depression in older adults
Sep 17, 2021
Sleep disturbance in older adults also is more common among those living with a partner and urinating at night.